Pharma73

📍 Lisboa, Portugal🗓 Founded 2011👥 4 employees💰 Last funded Dec 2011
Biotechnology Research🌐 pharma73.com
Website LinkedIn
Pharma73 is a Portuguese start-up, dedicated to the development, production and commercialization of a new generation of enhanced performance High Functionality Excipients (HFE’s). Pharma73’s Shareholders are Portuguese R&D company 73100, Lda, and Venture Capital Fund FCR ACTEC II, managed by Portugal Ventures. Pharma73’s natural biopolymer products whose unique properties enable their use as high functionality excipients in a multiplicity of pharmaceutical, food and cosmetics products, are obtained through a proprietary fermentation technology. The company was created in October 2011, with the purpose of developing the production of new high functionality excipients from biopolymers produced by microbial fermentation developed from research and development projects developed by it’s R&D teams in research projects executed at the Chemistry Department of Faculdade de Ciências e Tecnologia at Universidade Nova de Lisboa (FCT/UNL), in Lisbon. Since 2011 and up to now, Pharma73 has engaged on the Proof-of-concept stage of its biopolymer production technology platform and is planning market entry of it’s first products in 2019.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2011
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
Portugal
1
Frequently asked questions
Who invested in Pharma73?
Pharma73 has 1 investor on record on gritt.io, including 1 early-stage backers.
When did Pharma73 last raise funding?
The most recent investment in Pharma73 recorded on gritt.io was in December 2011.
When was Pharma73 founded?
Pharma73 was founded in 2011.
What industry is Pharma73 in?
Pharma73 operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Pharma73 based?
Pharma73 is headquartered in Lisboa, Portugal.